1. Home
  2. UUUU vs BEAM Comparison

UUUU vs BEAM Comparison

Compare UUUU & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Fuels Inc (Canada)

UUUU

Energy Fuels Inc (Canada)

HOLD

Current Price

$14.18

Market Cap

3.2B

Sector

Industrials

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

N/A

Current Price

$29.16

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UUUU
BEAM
Founded
1987
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.6B
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
UUUU
BEAM
Price
$14.18
$29.16
Analyst Decision
Strong Buy
Buy
Analyst Count
6
12
Target Price
$19.92
$50.75
AVG Volume (30 Days)
6.8M
1.6M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
82.31
EPS
N/A
N/A
Revenue
$65,922,000.00
$24,000.00
Revenue This Year
$126.63
N/A
Revenue Next Year
$36.80
$33.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
33.33
52 Week Low
$10.69
$16.52
52 Week High
$27.90
$38.26

Technical Indicators

Market Signals
Indicator
UUUU
BEAM
Relative Strength Index (RSI) 49.51 52.90
Support Level $13.65 $28.40
Resistance Level $16.63 $31.98
Average True Range (ATR) 0.82 1.41
MACD -0.03 0.29
Stochastic Oscillator 22.32 62.91

Price Performance

Historical Comparison
UUUU
BEAM

About UUUU Energy Fuels Inc (Canada)

Energy Fuels Inc is a critical mineral company based in the U.S. It produces several critical minerals, including uranium, vanadium, REEs (including NdPr, Dy and Tb) and HMS (including titanium and zirconium minerals). The company's project portfolio comprises uranium properties like Pinyon Plain Project, White Mesa Mill, Roca Honda Project, etc.; Heavy Minerals Sands project like Vara Mada Project, Donald Project, Bahia Project, etc.; the Nichols Ranch Project, and several other properties. The firm's reportable segments are: Uranium, REE, and HMS. Key revenue is generated from the Uranium segment, which is involved in conventional and ISR uranium extraction, recovery and sales of uranium from mineral properties, and the recycling of uranium-bearing materials generated by third parties.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: